CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY (DEFICIT) AND MEZZANINE EQUITY - USD ($)	Total	Common Stock	Preferred Stock	Treasury Stock	Additional Paid-In Capital	Accumulated Deficit	Accumulated Other Comprehensive Income (Loss)
Balance, shares at Dec. 31, 2020		13,485,128		(415,328)
Balance, amount at Dec. 31, 2020	$ (4,161,013)	$ 13,484	$ 0	$ (611,854)	$ 14,333,285	$ (18,750,824)	$ 854,896
Foreign currency translation adjustment, net	(473,578)	0	0	$ 0	0	0	(473,578)
Sale of treasury stock to third party, shares				65,000
Sale of treasury stock to third party, amount	250,000	$ 0	0	$ 650	249,350	0	0
Restricted stock issued to a consultant, shares		1,800,000
Restricted stock issued to a consultant, amount	1,189,450	$ 1,800	0		1,187,650
Conversion of notes payable into shares of common stock, shares		781,819
Conversion of notes payable into shares of common stock, amount	2,564,364	$ 782	0	0	2,563,582	0	0
Net loss	(2,173,903)	$ 0	0	$ 0	0	(2,173,903)	0
Balance, shares at Mar. 31, 2021		16,066,947		(350,328)
Balance, amount at Mar. 31, 2021	(2,804,680)	$ 16,066	0	$ (611,204)	18,333,867	(20,924,727)	381,318
Balance, shares at Dec. 31, 2021		17,544,509		(387,424)
Balance, amount at Dec. 31, 2021	4,379,463	$ 17,544	0	$ (816,707)	39,675,753	(34,345,506)	(151,621)
Foreign currency translation adjustment, net	(405,229)	$ 0	0	0	0	0	(405,229)
Conversion of notes payable into shares of common stock, shares		238,000
Conversion of notes payable into shares of common stock, amount	973,420	$ 238	0	0	973,182	0	0
Net loss	203,347	0	$ 0	0	0	203,347	0
Issuance of Series A preferred stock, net of issuance costs of $547,700, shares			6,000
Issuance of Series A preferred stock, net of issuance costs of $547,700, amount	0	$ 0	$ 5,452,300	0	0	0	0
Cashless exercise of warrants, shares		829,471
Cashless exercise of warrants, amount	0	$ 829	$ 0	$ 0	(829)	0	0
Balance, shares at Mar. 31, 2022		18,611,980	6,000	(387,424)
Balance, amount at Mar. 31, 2022	$ 5,151,001	$ 18,611	$ 5,452,300	$ (816,707)	$ 40,648,106	$ (34,142,159)	$ (556,850)